Literature DB >> 22993201

Psychometric tests for diagnosing minimal hepatic encephalopathy.

Karin Weissenborn1.   

Abstract

While it is consensus that minimal hepatic encephalopathy (mHE) has significant impact on a patient's daily living, and thus should be diagnosed and treated, there is no consensus about the optimal diagnostic tools. At present the most frequently used psychometric methods for diagnosing minimal hepatic encephalopathy are the Inhibitory Control Test and the Psychometric Hepatic Encephalopathy Score PHES. Another frequently used method is Critical Flicker Frequency. The PHES and the Repeatable Battery for the Assessment of Neuropsychological Status have been recommended for diagnosing mHE by a working party commissioned by the International Society for Hepatic Encephalopathy and Nitrogen Metabolism. Recently the Continuous Reaction Time Test, which has been used in the 1980ies, has gained new interest. Today, no data are available that allow to decide which of these methods is the most appropriate. In fact, even basic information such as dependence on age, sex and education or influence of diseases that frequently accompany liver cirrhosis upon test results is missing for most of them. Future studies must address these questions to improve diagnosis of mHE.

Entities:  

Mesh:

Year:  2012        PMID: 22993201     DOI: 10.1007/s11011-012-9336-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

Review 1.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics.

Authors:  Alan H Lockwood; Karin Weissenborn; Martin Bokemeyer; U Tietge; Wolfgang Burchert
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

Review 4.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Improving the inhibitory control task to detect minimal hepatic encephalopathy.

Authors:  Piero Amodio; Lorenzo Ridola; Sami Schiff; Sara Montagnese; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Maria Trezza; Chiara Marzano; Cristiana Flaiban; Paolo Angeli; Giorgia Cona; Patrizia Bisiacchi; Angelo Gatta; Oliviero Riggio
Journal:  Gastroenterology       Date:  2010-05-11       Impact factor: 22.682

6.  Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2011-04-12       Impact factor: 3.584

7.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

8.  Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.

Authors:  Mette Munk Lauridsen; Henning Grønbæk; Esben B Næser; Steffen T Leth; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

9.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

Review 10.  Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.

Authors:  Christopher Randolph; Robin Hilsabeck; Ainobu Kato; Parampreet Kharbanda; Yu-Yuan Li; Daniela Mapelli; Lisa D Ravdin; Manuel Romero-Gomez; Andrea Stracciari; Karin Weissenborn
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

View more
  20 in total

Review 1.  PET and MR imaging of neuroinflammation in hepatic encephalopathy.

Authors:  Yun Yan Su; Gui Fen Yang; Guang Ming Lu; Shawn Wu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2014-12-17       Impact factor: 3.584

2.  Treatment options for covert hepatic encephalopathy.

Authors:  Nisheet Waghray; Abhijeet Waghray; Kevin Mullen
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

3.  Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.

Authors:  Meghan NeSmith; Joseph Ahn; Steven L Flamm
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-02

Review 4.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

Review 5.  The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy.

Authors:  M M Lauridsen; M Thiele; N Kimer; H Vilstrup
Journal:  Metab Brain Dis       Date:  2013-01-10       Impact factor: 3.584

6.  Cognitive dysfunction and hepatitis C virus infection.

Authors:  Antonio Solinas; Maria Rita Piras; Angelo Deplano
Journal:  World J Hepatol       Date:  2015-05-08

7.  Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.

Authors:  M M Lauridsen; O B Schaffalitzky de Muckadell; H Vilstrup
Journal:  Metab Brain Dis       Date:  2015-05-29       Impact factor: 3.584

Review 8.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

9.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

10.  Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

Authors:  Su-Wen Li; Kai Wang; Yong-Qiang Yu; Hai-Bao Wang; Yuan-Hai Li; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.